FilingSEC EDGAR8-K
Rein Therapeutics Receives Nasdaq Delisting Warning for Minimum Bid Price Deficiency
· SEC accepted
StageDelisting Warning
Filing content
The company must regain compliance with the minimum bid price requirement by February 17, 2027, after its common stock closed below $1.00 for 30 consecutive trading days.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…